VenatoRx
PrivateLast Round
Grant
Oct 10, 2023
Total Funding Raised
$334.9M
Momentum Score
25 /100
Company Overview
Venatorx Pharmaceuticals is a biopharmaceutical company focused on developing antibacterial and antiviral drugs to combat multi-drug-resistant infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
antimicrobial resistanceAMRbeta-lactamase inhibitordrug-resistant infectionssuperbugsantibiotic developmentnovel anti-infectivesBL/BLI antibioticpenicillin-binding protein inhibitorsPBP inhibitorscomplicated urinary tract infectionscUTIgram-negative bacteriaBARDA fundingpharmaceutical licensingpre-commercial pharma
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VenatoRx Comps
Public and private peers based on sector, stage, and business model.
VenatoRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 10, 2023 | ||||
| Grant | Oct 3, 2022 | ||||
| Series C | Apr 4, 2022 | ||||
| Grant | Jul 27, 2020 | ||||
| Grant | Nov 25, 2019 | ||||
Grant | Feb 28, 2019 |
VenatoRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AMR Action Fund | Series C |
| CARB-X | Grant |
| Foresite Capital | Series B |
| Versant Ventures | Series B |
| Abingworth | Series B, Series C |
| Defense Threat Reduction Agency | Grant |
| Wellcome Trust | Grant |
VenatoRx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VenatoRx's valuation, stock price, and market status.
Firmographic Details
HeadquartersMalvern, Pennsylvania
Employee Range40
Year Founded2010
Last FundingOct 10, 2023
